![[up]](/style/images/multi_up.png)
Up a levelGroup by: Item Type | Date
Jump to: Journal article
Number of items: 2.
Journal article
Pfirrmann, M.; Mahon, F.-X.; Guilhot, J.; Richter, J.; Almeida, A.; Janssen, J. J.; Mayer, J.; Koskenvesa, P.; Panayiotidis, P.; Olsson-Stromberg, U.; Berger, M. G.; Diamond, J.; Ehrencrona, H.; Kairisto, V.; Polakova, K. Machova; Müller, M. C.; Mustjoki, S.; Hochhaus, A.; Saussele, S. und Hjorth-Hansen, H.
(2017):
Chronic Myeloid Leukemia Patients Were Not Different In Molecular Relapse after Stopping Imatinib in Mr4 Whether Residual Disease Was Detected or Not - When Adjusting For Number of Control Transcripts.
In: Haematologica, Vol. 102: p. 153
Richter, J.; Mahon, F. X.; Guilhot, J.; Hjorth-Hansen, H.; Almeida, A.; Janssen, J. J.; Mayer, J.; Porkka, K.; Panayiotidis, P.; Olsson-Strömberg, U.; Berger, M. G.; Diamond, J.; Ehrencrona, H.; Kairisto, V.; Polakova, K. Machova; Müller, M. C.; Mustjoki, S.; Hochhaus, A.; Pfirrmann, M. und Saußele, S.
(2016):
Stopping tyrosine kinase inhibitors in a very large cohort of European chronic myeloid leukemia patients: results of the euro-ski trial.
In: Haematologica, Vol. 101: pp. 22-23